帕斯卡尔Ace中较小的间隔器对剩余的中枢孔区域的影响
Michael Paukovitsch1, Dominik Felbel1, Marijana Tadic1
1Ulm University Heart Center, Department of Cardiology, Albert-Einstein-Allee 23, 89081, Ulm, Germany.
概括
与PASCAL Ace.相比,PASCAL P10设备具有更大的间隔器,可以在与PASCAL Ace.相比的交叉导管边缘到边缘修复 (M-TEER) 期间保持更大的 mitra 门孔面积 (MVOA). 这表明,Ace可能会增加FMR患者明显孔径缩小的风险.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 医疗器械 医疗器械
背景情况:
- 交叉导管边缘到边缘修复 (M-TEER) 有效地治疗功能性交叉导管吐 (FMR).
- 潜在的M-TEER风险之一是由于孔径面积的减少而导致中枢狭窄的产生.
- 设备的选择和间隔尺寸可能会影响术后的 mitra 孔区域 (MVOA).
研究的目的:
- 为了比较PASCAL P10装置 (较大的间隔器) 与PASCAL Ace装置 (较小的间隔器) 在M-TEER期间对MVOA减少的影响.
- 评估设备特征对FMR患者中阳性静脉狭窄风险的影响.
主要方法:
- 连续接受M-TEER的FMR患者的回顾性分析,使用单个PASCAL设备.
- 包括标准:非复杂的解剖学,基线MVOA≥3.5cm2.
- 用3D多平面重建和平面测量来测量MVOA减少的过程内跨食道心声学.
主要成果:
- 分析了72名患者;32人接受了帕斯卡P10设备.
- 虽然基线MVOA类似,但P10患者的残留MVOA较大 (2.7 ± 0.7 cm2) 与Ace患者 (2.3 ± 0.6 cm2) 相比.
- 在P10患者 (-45.9 ± 7.6%) 与Ace患者 (-56.3 ± 7.0%) 之间,相对MVOA的相对减少显著较小.
结论:
- 拥有更大的间隔器的PASCAL P10设备在非复杂解剖的FMR患者中保留了更大的MVOA,实现了类似的MR减少.
- 帕斯卡Ace设备,特别是在基线MVOA较小的患者中,可能会带来较高的明显孔径缩小和潜在的阳性狭窄的风险.
相关概念视频
Mitral Valve Prolapse I: Introduction
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...


